Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

McKesson
Moodys
Boehringer Ingelheim
Express Scripts
Dow
Baxter

Last Updated: June 27, 2022

KERYDIN Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard

When do Kerydin patents expire, and when can generic versions of Kerydin launch?

Kerydin is a drug marketed by Anacor Pharms Inc and is included in one NDA.

The generic ingredient in KERYDIN is tavaborole. There are six drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the tavaborole profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Kerydin

A generic version of KERYDIN was approved as tavaborole by ENCUBE on October 13th, 2020.

  Try it Free

Drug patent expirations by year for KERYDIN
Drug Prices for KERYDIN

See drug prices for KERYDIN

Recent Clinical Trials for KERYDIN

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
PfizerPhase 4

See all KERYDIN clinical trials

Pharmacology for KERYDIN
Paragraph IV (Patent) Challenges for KERYDIN
Tradename Dosage Ingredient Strength NDA ANDAs Submitted Submissiondate
KERYDIN Topical Solution tavaborole 5% 204427 13 2018-07-09

US Patents and Regulatory Information for KERYDIN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Anacor Pharms Inc KERYDIN tavaborole SOLUTION;TOPICAL 204427-001 Jul 7, 2014 AB RX Yes Yes See Plans and Pricing See Plans and Pricing See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

International Patents for KERYDIN

When does loss-of-exclusivity occur for KERYDIN?

Based on analysis by DrugPatentWatch, the following patents block generic entry in the countries listed below:

Australia

Patent: 06214247
Estimated Expiration: See Plans and Pricing

Patent: 06333527
Estimated Expiration: See Plans and Pricing

Patent: 10203096
Estimated Expiration: See Plans and Pricing

Patent: 11200994
Estimated Expiration: See Plans and Pricing

Brazil

Patent: 0608431
Estimated Expiration: See Plans and Pricing

Patent: 0621279
Estimated Expiration: See Plans and Pricing

Canada

Patent: 97982
Estimated Expiration: See Plans and Pricing

Patent: 35680
Estimated Expiration: See Plans and Pricing

China

Patent: 1160124
Estimated Expiration: See Plans and Pricing

Patent: 1505603
Estimated Expiration: See Plans and Pricing

Patent: 1914109
Estimated Expiration: See Plans and Pricing

Patent: 2532180
Estimated Expiration: See Plans and Pricing

Patent: 5949230
Estimated Expiration: See Plans and Pricing

Patent: 6008571
Estimated Expiration: See Plans and Pricing

Patent: 6008583
Estimated Expiration: See Plans and Pricing

Cyprus

Patent: 16454
Estimated Expiration: See Plans and Pricing

Patent: 20695
Estimated Expiration: See Plans and Pricing

Denmark

Patent: 43304
Estimated Expiration: See Plans and Pricing

Patent: 87796
Estimated Expiration: See Plans and Pricing

Patent: 24932
Estimated Expiration: See Plans and Pricing

European Patent Office

Patent: 53251
Estimated Expiration: See Plans and Pricing

Patent: 76536
Estimated Expiration: See Plans and Pricing

Patent: 43304
Estimated Expiration: See Plans and Pricing

Patent: 87796
Estimated Expiration: See Plans and Pricing

Patent: 24932
Estimated Expiration: See Plans and Pricing

Hong Kong

Patent: 09735
Estimated Expiration: See Plans and Pricing

Patent: 60139
Estimated Expiration: See Plans and Pricing

Patent: 21956
Estimated Expiration: See Plans and Pricing

Patent: 28917
Estimated Expiration: See Plans and Pricing

Hungary

Patent: 26021
Estimated Expiration: See Plans and Pricing

Patent: 40060
Estimated Expiration: See Plans and Pricing

Patent: 54365
Estimated Expiration: See Plans and Pricing

Patent: 000019
Estimated Expiration: See Plans and Pricing

Israel

Patent: 5080
Estimated Expiration: See Plans and Pricing

Patent: 2402
Estimated Expiration: See Plans and Pricing

Patent: 7156
Estimated Expiration: See Plans and Pricing

Japan

Patent: 38912
Estimated Expiration: See Plans and Pricing

Patent: 46876
Estimated Expiration: See Plans and Pricing

Patent: 09140
Estimated Expiration: See Plans and Pricing

Patent: 08535781
Estimated Expiration: See Plans and Pricing

Patent: 09526751
Estimated Expiration: See Plans and Pricing

Patent: 10248265
Estimated Expiration: See Plans and Pricing

Patent: 13018778
Estimated Expiration: See Plans and Pricing

Patent: 14132031
Estimated Expiration: See Plans and Pricing

Patent: 15117243
Estimated Expiration: See Plans and Pricing

Patent: 16020374
Estimated Expiration: See Plans and Pricing

Patent: 16199561
Estimated Expiration: See Plans and Pricing

Patent: 17105826
Estimated Expiration: See Plans and Pricing

Lithuania

Patent: 2020524
Estimated Expiration: See Plans and Pricing

Luxembourg

Patent: 0157
Estimated Expiration: See Plans and Pricing

Mexico

Patent: 5993
Estimated Expiration: See Plans and Pricing

Patent: 9262
Estimated Expiration: See Plans and Pricing

Netherlands

Patent: 1049
Estimated Expiration: See Plans and Pricing

New Zealand

Patent: 0448
Estimated Expiration: See Plans and Pricing

Patent: 8297
Estimated Expiration: See Plans and Pricing

Patent: 8441
Estimated Expiration: See Plans and Pricing

Poland

Patent: 53251
Estimated Expiration: See Plans and Pricing

Patent: 43304
Estimated Expiration: See Plans and Pricing

Patent: 87796
Estimated Expiration: See Plans and Pricing

Patent: 24932
Estimated Expiration: See Plans and Pricing

Portugal

Patent: 53251
Estimated Expiration: See Plans and Pricing

Patent: 43304
Estimated Expiration: See Plans and Pricing

Patent: 87796
Estimated Expiration: See Plans and Pricing

Patent: 24932
Estimated Expiration: See Plans and Pricing

Russian Federation

Patent: 14906
Estimated Expiration: See Plans and Pricing

Patent: 06947
Estimated Expiration: See Plans and Pricing

Patent: 07134429
Estimated Expiration: See Plans and Pricing

Patent: 08131324
Estimated Expiration: See Plans and Pricing

Patent: 10133524
Estimated Expiration: See Plans and Pricing

Patent: 16145916
Estimated Expiration: See Plans and Pricing

Slovenia

Patent: 43304
Estimated Expiration: See Plans and Pricing

Patent: 87796
Estimated Expiration: See Plans and Pricing

Patent: 24932
Estimated Expiration: See Plans and Pricing

South Africa

Patent: 0707408
Estimated Expiration: See Plans and Pricing

Patent: 0905950
Estimated Expiration: See Plans and Pricing

Patent: 1005380
Estimated Expiration: See Plans and Pricing

Patent: 1506944
Estimated Expiration: See Plans and Pricing

South Korea

Patent: 1337045
Estimated Expiration: See Plans and Pricing

Patent: 1337068
Estimated Expiration: See Plans and Pricing

Patent: 1426220
Estimated Expiration: See Plans and Pricing

Patent: 1456815
Estimated Expiration: See Plans and Pricing

Patent: 070112390
Estimated Expiration: See Plans and Pricing

Patent: 080110984
Estimated Expiration: See Plans and Pricing

Patent: 100105869
Estimated Expiration: See Plans and Pricing

Patent: 130095330
Estimated Expiration: See Plans and Pricing

Patent: 130100019
Estimated Expiration: See Plans and Pricing

Spain

Patent: 14095
Estimated Expiration: See Plans and Pricing

Patent: 40966
Estimated Expiration: See Plans and Pricing

Patent: 86981
Estimated Expiration: See Plans and Pricing

Patent: 72962
Estimated Expiration: See Plans and Pricing

Generics may enter earlier, or later, based on new patent filings, patent extensions, patent invalidation, early generic licensing, generic entry preferences, and other factors.

See the table below for additional patents covering KERYDIN around the world.

Country Patent Number Title Estimated Expiration
Russian Federation 2007134429 БОРСОДЕРЖАЩИЕ МАЛЫЕ МОЛЕКУЛЫ See Plans and Pricing
Netherlands 301049 See Plans and Pricing
South Korea 20070112390 BORON-CONTAINING SMALL MOLECULES See Plans and Pricing
Japan 2017105826 ホウ素含有小分子 (BORON-CONTAINING SMALL MOLECULE) See Plans and Pricing
>Country >Patent Number >Title >Estimated Expiration

Supplementary Protection Certificates for KERYDIN

Patent Number Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
2343304 301049 Netherlands See Plans and Pricing PRODUCT NAME: CRISABOROLE, DESGEWENST IN DE VORM VAN EEN FARMACEUTISCH AANVAARDBAAR ZOUT; REGISTRATION NO/DATE: EU/1/19/1421 20200401
2343304 23/2020 Austria See Plans and Pricing PRODUCT NAME: CRISABOROL, GEGEBENENFALLS IN FORM EINES PHARMAZEUTISCH AKZEPTABLEN SALZES; REGISTRATION NO/DATE: EU/1/19/1421 (MITTEILUNG) 20200401
2343304 122020000038 Germany See Plans and Pricing PRODUCT NAME: CRISABOROL, GEGEBENENFALLS IN FORM EINES PHARMAZEUTISCH ANNEHMBAREN SALZES DAVON; REGISTRATION NO/DATE: EU/1/19/1421 20200327
2343304 2090017-1 Sweden See Plans and Pricing PRODUCT NAME: CRISABOROLE, OPTIONALLY IN THE FORM OF PHARMACEUTICALLY ACCEPTABLE SALT; REG. NO/DATE: EU/1/19/1421 20200401
>Patent Number >Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow
Merck
Baxter
Express Scripts
Boehringer Ingelheim
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.